Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Mattel
MAT
$4.23B
| $6.01M | ﹤0.01% |
318,316
+127,938
| +67% | +$2.49M |
|
1927
Outfront Media
OUT
$5.5B
| $6.01M | ﹤0.01% |
437,363
-17,528
| -4% | -$198K |
|
1928
Avnet
AVT
$7.92B
| $6M | ﹤0.01% |
119,046
+70,822
| +147% | +$3.37M |
|
1929
WSFS Financial
WSFS
$4.15B
| $5.96M | ﹤0.01% |
129,822
+51,924
| +67% | +$2.04M |
|
|
DNB
1930
DELISTED
Dun & Bradstreet
DNB
| $5.96M | ﹤0.01% |
509,464
+369,599
| +264% | +$3.76M |
|
1931
CALL
SolarEdge
SEDG
$1.95B
| $5.95M | ﹤0.01% |
63,600
+16,400
| +35% | +$1.49M |
|
1932
Broadstone Net Lease
BNL
$4.02B
| $5.95M | ﹤0.01% |
345,573
+228,183
| +194% | +$3.52M |
|
1933
Coursera
COUR
$1.54B
| $5.95M | ﹤0.01% |
307,047
+266,303
| +654% | +$5.09M |
|
1934
PUT
Atlassian
TEAM
$37.8B
| $5.95M | ﹤0.01% |
+25,000
| New | +$4.91M |
|
1935
Rush Enterprises Class A
RUSHA
$6.22B
| $5.91M | ﹤0.01% |
117,592
+62,147
| +112% | +$2.51M |
|
1936
PUT
Etsy
ETSY
$7.85B
| $5.91M | ﹤0.01% |
+72,900
| New | +$5.22M |
|
1937
iShares MSCI Australia ETF
EWA
$1.45B
| $5.9M | ﹤0.01% |
242,526
+19,217
| +9% | +$426K |
|
1938
PUT
Becton Dickinson
BDX
$48.2B
| $5.9M | ﹤0.01% |
24,200
-5,000
| -17% | -$1.23M |
|
1939
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
| $5.9M | ﹤0.01% |
213,936
+112,263
| +110% | +$2.44M |
|
1940
Corcept Therapeutics
CORT
$12B
| $5.9M | ﹤0.01% |
181,551
+107,565
| +145% | +$2.95M |
|
1941
Recursion Pharmaceuticals
RXRX
$1.73B
| $5.88M | ﹤0.01% |
596,558
+38,787
| +7% | +$277K |
|
1942
Gaotu Techedu
GOTU
$436M
| $5.88M | ﹤0.01% |
1,624,672
+1,522,161
| +1,485% | +$4.28M |
|
|
X
1943
CALL
DELISTED
US Steel
X
| $5.87M | ﹤0.01% |
+120,600
| New | +$4.39M |
|
1944
Andersons Inc
ANDE
$2.22B
| $5.86M | ﹤0.01% |
101,795
+39,289
| +63% | +$2.04M |
|
|
GMS
1945
DELISTED
GMS Inc
GMS
| $5.84M | ﹤0.01% |
70,872
+48,623
| +219% | +$3.26M |
|
1946
PUT
Royal Caribbean
RCL
$85.6B
| $5.83M | ﹤0.01% |
45,000
-645,000
| -93% | -$65.7M |
|
1947
CALL
Occidental Petroleum
OXY
$55.9B
| $5.81M | ﹤0.01% |
+97,300
| New | +$5.94M |
|
1948
Celldex Therapeutics
CLDX
$3.28B
| $5.79M | ﹤0.01% |
145,894
+2,431
| +2% | +$71.5K |
|
|
MASI
1949
DELISTED
Masimo
MASI
| $5.77M | ﹤0.01% |
49,260
+17,932
| +57% | +$1.67M |
|
1950
Graham Holdings Company
GHC
$5.02B
| $5.76M | ﹤0.01% |
8,274
+5,265
| +175% | +$3.28M |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.